Juan Manuel Rocha Angel | Nanotechnology | Best Researcher Award

Best Researcher Award

Juan Manuel Rocha Angel
McGill University, Canada
Juan Manuel Rocha Angel
Affiliation McGill University
Country Canada
Documents 1
Subject Area Nanotechnology
Event International Environmental Scientists Award
ORCID 0009-0005-7972-3221

Juan Manuel Rocha Angel is a researcher affiliated with McGill University in Montreal, Quebec, Canada, where his academic activities are associated with the field of Bioengineering. His emerging scholarly contributions focus on advanced therapeutic technologies, particularly the development and optimization of messenger RNA (mRNA) delivery systems and nanotechnology-enabled biomedical applications. Through his published work, Juan Manuel Rocha Angel has demonstrated an interest in addressing contemporary challenges in therapeutic formulation and drug delivery by exploring innovative approaches that support the advancement of precision medicine and translational biomedical research.[1]

Abstract

This article presents an academic overview of Juan Manuel Rocha Angel and his research activities within the interdisciplinary fields of bioengineering, nanotechnology, and therapeutic formulation. His scholarly work contributes to the growing body of knowledge surrounding mRNA-based therapeutics and lipid nanoparticle delivery systems. The available publication record highlights an emphasis on innovative formulation strategies intended to improve therapeutic effectiveness, stability, and clinical applicability. These research themes align with current global efforts to advance next-generation biomedical technologies and precision medicine initiatives.[2]

Keywords

Nanotechnology; Bioengineering; mRNA Therapeutics; Lipid Nanoparticles; Drug Delivery Systems; Pharmaceutical Sciences; Biomedical Innovation; Therapeutic Formulation.

Introduction

Recent advances in biotechnology have increased the importance of mRNA-based therapeutic platforms and nanoparticle-mediated delivery systems. Researchers working in this area contribute to the development of safer and more efficient therapeutic technologies capable of addressing complex medical challenges. Within this context, Juan Manuel Rocha Angel has participated in research exploring emerging approaches in mRNA-lipid nanoparticle formulations, a rapidly evolving field with significant implications for modern medicine and pharmaceutical development.[3]

Research Profile

Juan Manuel Rocha Angel is affiliated with McGill University and is associated with bioengineering-related research activities. His academic profile reflects engagement with multidisciplinary biomedical sciences, combining principles from engineering, nanotechnology, pharmaceutical sciences, and therapeutic development. His published work demonstrates a commitment to investigating advanced delivery systems that may enhance the efficacy and accessibility of future therapeutic interventions.[1]

Research Contributions

A notable contribution from Juan Manuel Rocha Angel involves the examination of non-conventional methodologies in mRNA-LNP formulation. This work discusses emerging strategies designed to improve formulation performance and therapeutic outcomes. By addressing technical and translational considerations, the research contributes to ongoing scientific discussions concerning optimization of nucleic acid delivery platforms and future therapeutic applications.[2]

Publications

  • Emerging Non-Conventional Approaches in mRNA-LNP Formulation for Therapeutic Applications, Pharmaceutics, 2026.

Research Impact

Although currently represented by a limited publication record, the research area addressed by Juan Manuel Rocha Angel is highly relevant to contemporary biomedical innovation. Studies involving mRNA delivery systems and nanotechnology-based therapeutic platforms have become central to modern pharmaceutical research. Contributions within this domain support scientific understanding of advanced formulation technologies and provide a foundation for future developments in personalized and precision medicine.[4]

Award Suitability

The research profile of Juan Manuel Rocha Angel demonstrates alignment with the objectives of the International Environmental Scientists Award, particularly in recognizing emerging scientific contributions that support innovation, sustainability, and human well-being through advanced technological research. His involvement in interdisciplinary biomedical and nanotechnology-related investigations reflects qualities commonly associated with academic excellence, scientific curiosity, and commitment to addressing real-world challenges through evidence-based research.[5]

Conclusion

Juan Manuel Rocha Angel represents an emerging researcher whose work contributes to the advancement of nanotechnology-enabled therapeutic systems. Through his affiliation with McGill University and his published investigation into innovative mRNA-LNP formulations, he participates in a field of considerable scientific and societal importance. His research interests, interdisciplinary perspective, and focus on next-generation therapeutic technologies provide a meaningful basis for recognition within academic and professional award programs.[6]

References

  1. ORCID. (n.d.). Juan Manuel Rocha Angel Research Profile.
    https://orcid.org/0009-0005-7972-3221
  2. Rocha Angel, J. M. (2026). Emerging Non-Conventional Approaches in mRNA-LNP Formulation for Therapeutic Applications. Pharmaceutics.
    https://doi.org/10.3390/pharmaceutics18050527
  3. MDPI. (2026). Pharmaceutics Journal Publication Record.
    https://doi.org/10.3390/pharmaceutics18050527
  4. McGill University. (n.d.). Research and Innovation Overview.
  5. International Environmental Scientists Award. (n.d.). Award Program Information.
    environmentalscientists.org
  6. Elsevier. (n.d.). Scopus author details: Juan Manuel Rocha Angel.

Yanfang Li | Nanotechnology | Research Excellence Award

Dr. Yanfang Li | Nanotechnology | Research Excellence Award

Dr. Yanfang Li | Nanotechnology | Researcher at Hangzhou Dianzi University | China

Dr. Yanfang Li is a science-focused researcher at Hangzhou Dianzi University whose work bridges materials science, micro and nanorobotics, magnetic sensing, and biomedical engineering, establishing a strong and steadily growing international research profile. Dr. Yanfang Li received advanced academic training in science and engineering, developing a solid foundation in nanomaterials, functional composites, and micro–nano fabrication technologies, which has shaped a research career at the intersection of physics, chemistry, and biomedicine. Professionally, Dr. Yanfang Li has accumulated extensive experience as an academic researcher and collaborative scientist, contributing to high-quality publications in leading peer-reviewed journals including Small, Advanced Healthcare Materials, ACS Applied Materials and Interfaces, Computers in Biology and Medicine, and Applied Surface Science, while actively engaging in multidisciplinary research teams that integrate materials design, magnetic actuation, and biomedical applications.

Citation Metrics (Google Scholar)

500

400

300

200

100

0

Citations
356

i10index
11

h-index
10

🟦 Citations 🟥 Documents 🟩 h-index

View Google Scholar Profile

Featured Publications:

 

Tianyi Gao | Nanotechnology | Best Researcher Award

Ms. Tianyi Gao | Nanotechnology | Best Researcher Award

Postgraduate | Nanotechnology and Catalysis Research Centre | China

Ms. Tianyi Gao is a passionate researcher specializing in nanotechnology and electrochemical energy systems, currently pursuing her Master of Applied Science at the University of Malaya, Malaysia. Her research interests encompass electrochemical energy storage, energy conversion, and computational materials science, focusing on batteries, supercapacitors, and catalytic reactions for sustainable energy technologies. She has made significant contributions through publications in reputed journals such as Toxics, Journal of Physics: Conference Series, and Catalysts, where her work on MXene-based materials and transition metal dichalcogenides has gained notable attention. Ms. Tianyi Gao has participated in several advanced research projects, including the development of MOF-derived metal oxides and high-entropy alloys for energy applications, as well as microstructural analysis of duplex stainless steels and high-entropy alloys in collaboration with international institutions. Skilled in computational simulations, material characterization, and electrochemical analysis, she integrates both theoretical and experimental approaches to design high-performance materials. Her dedication to sustainable science, innovation, and academic excellence reflects her commitment to addressing global energy challenges.

Profile: Orcid 

Featured Publications

Gao, T., Li, Y., Lai, C. W., Xiang, P., Badruddin, I. A., Dhiman, P., & Kumar, A. (2025). Recent advances in transition metal dichalcogenide-based electrodes for asymmetric supercapacitors. Catalysts, 15(10), 945.

Li, Y., Li, Y., Zhang, S., Gao, T., Gao, Z., Lai, C. W., Xiang, P., & Yang, F. (2025). Global distribution, ecotoxicity, and treatment technologies of emerging contaminants in aquatic environments: A recent five-year review. Toxics, 13(8), 616.

Gao, T., & Li, Z. (2023). Preparation of mesoporous γ-alumina from red mud waste. Journal of Physics: Conference Series, 2553(1), 012022.

Oluwaseun Adeniji | Nanotechnology | Best Researcher Award

Dr. Oluwaseun Adeniji | Nanotechnology | Best Researcher Award

Researcher | University of Johannesburg | South Africa

Oluwaseun Ola Adeniji is a passionate researcher with a strong background in microbiology, known for his work on antimicrobial resistance and environmental pathogens. With exceptional skills in laboratory techniques, scientific writing, and nanoparticle synthesis, he has made notable contributions to environmental microbiology and molecular biology. His research targets multidrug-resistant organisms in aquatic environments, with a focus on novel treatment approaches. A diligent team player and effective communicator, he has gained valuable experience in academic and industrial settings. Oluwaseun is eager to continue his impactful research as a postdoctoral fellow, contributing innovative solutions to global microbial resistance challenges.

Professional Profile

Scopus

Orcid

Google Scholar

Education

Oluwaseun earned his PhD in Biochemistry and Microbiology from the University of Fort Hare, South Africa, where he studied antimicrobial combination therapies targeting integron-mediated multidrug resistance in aquatic pathogens. He previously completed an MSc and BSc (Hons) in the same department with distinction, investigating Enterococcus species and Vibrio pathogens in recreational and wastewater environments. His academic journey began with diplomas from Osun State Polytechnic and Kaduna State Polytechnic in Nigeria, focusing on cassava fermentation and haemoglobin pattern analysis. His education combines a deep understanding of microbiological principles with hands-on analytical and water quality monitoring experience.

Experience

Oluwaseun has amassed significant academic and professional experience, serving as a tutor at the University of Fort Hare, where he assisted with microbiology practicals and grading. Before entering academia, he taught biology and basic science across several Nigerian high schools, demonstrating strong pedagogical and leadership skills. His early career included laboratory work as an industrial trainee at Covenant Hospital in Kaduna, where he gained clinical exposure. These cumulative experiences have refined his project management, teamwork, and technical capabilities, making him a versatile researcher prepared for advanced scientific inquiry and collaboration in multidisciplinary environments.

Research Interests

Oluwaseun’s research interests center around environmental microbiology, antimicrobial resistance, molecular diagnostics, and nanoparticle synthesis. He is particularly focused on integron-mediated multidrug resistance in aquatic pathogens like Enterococcus and Acinetobacter baumannii. His expertise includes applying PCR techniques, nanoparticle-antibiotic synergy studies, and environmental water quality monitoring using modern tools. Additionally, he explores nanomaterial-based solutions to mitigate antimicrobial resistance and promotes sustainable water safety practices. Oluwaseun’s interests are guided by a vision to advance health and environmental outcomes through innovative microbiological strategies and interdisciplinary approaches that merge molecular science, environmental health, and biotechnology.

Awards

Throughout his academic journey, Oluwaseun has consistently demonstrated excellence, earning distinction in both undergraduate and postgraduate studies. He was recognized by the University of Fort Hare for his outstanding performance and contributions to the Applied and Environmental Microbiology Research Group (AEMREG). His scholarly efforts and teamwork have earned him roles in several interdisciplinary research projects and reviewer responsibilities in esteemed journals. These acknowledgments reflect his commitment to academic excellence, scientific integrity, and impactful research. His consistent drive for excellence continues to position him as a strong candidate for prestigious research fellowships and global recognition in the field of microbiology.

Top Noted Publications

Title: Multiple Mycotoxin Contamination in Livestock Feed: Implications for Animal Health, Productivity, and Food Safety
Year: 2025
Cited by: 2

Title: Prevalence of Class 1 Integron and In Vitro Effect of Antibiotic Combinations of Multidrug-Resistant Enterococcus Species Recovered from the Aquatic Environment in the Eastern Cape Province, South Africa
Year: 2023
Cited by: 5

Title: Prevalence of Classes 1 and 2 Integrons in Multidrug-Resistant Acinetobacter baumannii Isolates Recovered from Some Aquatic Environment in South Africa
Year: 2022
Cited by: 12

Title: Antibacterial Activity of Metallic Nanoparticles Against Multidrug-Resistant Pathogens Isolated from Environmental Samples: Nanoparticles/Antibiotic Combination Therapy and Cytotoxicity Study
Year: 2022
Cited by: 9

Title: The Potential of Antibiotics and Nanomaterial Combinations as Therapeutic Strategies in the Management of Multidrug-Resistant Infections: A Review
Year: 2022
Cited by: 17

Conclusion

Based on his demonstrated scientific rigor, impactful publications, and commitment to tackling critical issues in microbiology and public health, Oluwaseun Ola Adeniji is highly suitable for the Best Researcher Award. His contributions reflect innovation, depth, and a forward-looking research vision that aligns with the award’s goals of recognizing excellence and leadership in research.